Publications

Difficulties in achieving suppression of viral replication in vertically HIV-1 infected infants early treated with d4T+ddI+NFV : The PENTA 7 Study.

18 Feb, 2002

Authors: Compagnucci A, Saidi Y, Chaix ML, et al. Published in: 9th Conference on Retroviruses and Opportunistic Infections February 24-28, 2002 – Seattle. Poster 809 – W.
Read More

TREC Response to Antiretroviral Therapy in HIV-infected Children in the PENTA 5 Trial

18 Feb, 2002

Authors: De Rossi A, Klein N, Walker AS, De Forni D, Babiker A, King D, Gibb DM for the PENTA Group. Published in: 9th Conference on Retroviruses and Opportunistic Infections,…
Read More

The Impact of HIV-1 Subtypes on Virological Response and Emergence of Resistance in the PENTA 5 Trial

18 Feb, 2002

Authors: Pillay D, Gibb DM, Walker AS, De Rossi A, Kaye S, Ait-Khaled M, Muñoz-Fernandez M, Babiker A for the PENTA Group. Published in: 9th Conference on Retroviruses and Opportunistic Infections,…
Read More

Pharmacokinetics (PK) of Nelfinavir (NFV) and its Active Metabolite (M8) in Very Young Infants Infected with Human Immunodeficiency Virus (HIV)

18 Apr, 2001

Authors: Litalien C, Faye A, Compagnucci A, Jacqz-Aigrain E. Published in: Pediatric Academic Societies 2001 Annual Meeting, April 28th – May 1st 2001, Baltimore MD. Abstract 2609.
Read More

Evolution of drug resistance in antiretroviral therapy-naïve children in PENTA 5

18 Apr, 2001

Authors: Loveday. C., Walker. A.S., Gibb. D.M., on behalf of the PENTA virology Group Published in:  Fifth International Workshop on HIV Drug Resistance and Treatment Strategies, 2001, Scottsdale, USA. Abstract …
Read More

T cell repopulation in HIV infected children on highly active anti-retroviral therapy (HAART)

18 Apr, 2001

Authors: King D J.S., Gotch F M., Larsson-Sciard E. Published in: Clin Exp Immunol.2001;125(3):447-454 Abstract In this pilot study, we address the nature of the re-population of the T-cell compartment…
Read More

Evaluation of Toxicity, Tolerability and Antiviral Activity of Early d4T+ddI+Nelfinavir (NFV) Therapy in HIV-1 Vertically Infected Infants : 24 Week Preliminary Results from the PENTA 7 Study

18 Feb, 2001

Authors: Faye A , Compagnucci A., Saidi Y; for the PENTA 7 Executive Committee Published in: 8th Conference on Retroviruses and Opportunistic Infections, February 4th-8th, 2001, Chicago. Poster 678
Read More

Nelfinavir doses should be increased in infants less than 3 months

18 Jul, 2000

Authors: Litalien C. Giaquinto C. Faye A. Mechinaud F. Grosch I. Compagnucci A. Jacqz-Aigrain E. Published in: XIII International AIDS Conference July 9th-14th 2000, Durban, South Africa. Abstract Mo PEB 2213…
Read More

Current evidence for the use of pediatric antiretroviral therapy – a PENTA analysis

19 Apr, 2000

Authors: Sharland M, Gibb DM, Giaquinto C. Published in: European Journal of Pediatrics 2000; 159:649-656.
Read More

Variable use of therpaeutic interventions for children with human immunodeficiency virus type 1 infection in Europe.

19 Apr, 2000

Authors: Bernardi S, Thorne C, Newell ML, Giaquinto C,Tovo PA, Rossi P. Published in: European Journal of Pediatrics 2000; 159(3):170-5
Read More

Reconstitution of the T-cell Pool in Treated, HIV-infected Children

18 Apr, 2000

Authors: King D, Gibb DM, Gotch F, Larsson-Sciard E. Published in: 7th Conference on Retroviruses and Opportunistic Infections, January 30th- February 2nd, 2000, Abstract 322., San Francisco. Abstract 322
Read More

Immune repopulation after HAART in previously untreated HIV-1 infected children

18 Apr, 2000

Authors: Gibb DM, Newberry A, Klein N, de Rossi A, Grosch-Wörner I, Babiker A Published in: Lancet.2000; 355: 1331-2 Abstract In 25 vertically HIV-infected children receiving highly-active antiretroviral therapy, a…
Read More

A randomised trial evaluating three NRTI regimens with and without Nelfinavir in HIV-infected children: 48 week follow-up from the PENTA 5 trial

18 Apr, 2000

Authors: Gibb. D. M. for the PENTA 5 Executive and the PENTA Steering Committee. Published in: Oral presentation at 5th International Congress on Drug Therapy in HIV Infection, Glasgow 22-26 October 2000 also published…
Read More

Drug resistance in a trial of nucleoside analogue and protease inhibitor therapy in children (PENTA 5)

18 Apr, 2000

Authors: Kaye S. on behalf of the PENTA Virology Committee. Published in: 5th International Congress on Drug Therapy in HIV Infection, October 22nd-26th 2000, Glasgow. P_308.
Read More

Parents’ attitudes to their HIV-infected children being enrolled into a placebo-controlled trial: the PENTA 1 trial. Paediatric European Network for Treatment of AIDS

01 Oct, 1999

Authors: Paediatric European Network for Treatment of AIDS (PENTA) Published in: HIV Med. 1999;1(1):25-31 Objective The study aimed to explore the experience of parents/care-givers to their child’s participation in a European randomized trial of immediate…
Read More

Plasma viral load and genotypic resistance patterns in children adding lamivudine to current reverse transcriptase inhibitor therapy (PENTA 4 Trial)

18 Apr, 1998

Authors:  Kaye S, Loveday C, Gibb DM., Newberry A. Published in: 4th International Congress, November 8ht-12th 1998, Glasgow.  P_305
Read More

A randomized double-blind trial of the addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase inhibitor therapy in HIV-infected children: the PENTA-4 trial

12 Apr, 1998

Authors: Aboulker JP, Babiker A, Carrière I, et al. Published in: AIDS.1998;12(14):F151-F160 Objective To evaluate the toxicity, tolerability and effect on laboratory markers of adding lamivudine (3TC) to nucleoside analogue…
Read More

HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA)

05 Mar, 1998

Authors: Paediatric European Network for Treatment of AIDS (PENTA) Published in: AIDS. 1998;12(4):F1-8 Background Plasma HIV-1 RNA levels are high in vertically infected infants. Information in older children is limited, particularly in those who have not received…
Read More
1 29 30 31 32